These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 636903)

  • 21. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Bloom FE
    Brain Res; 1982 Jan; 232(2):391-400. PubMed ID: 6322914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of subchronic lithium treatment on apomorphine-induced change in prolactin and growth hormone secretion.
    Goodnick PJ; Meltzer HY
    J Clin Psychopharmacol; 1983 Aug; 3(4):239-43. PubMed ID: 6411776
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
    Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenytoin-induced increase in growth hormone response to levodopa in adult males.
    D'Alessandro R; Cortelli P; Gallassi R; Ghisoli E; Montanaro N; Zoni E; Baruzzi A
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):715-9. PubMed ID: 6431057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of L-tryptophan on apomorphine-induced growth hormone secretion in normal subjects.
    Lal S; Young SN; Cervantes P; Guyda H
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):331-5. PubMed ID: 7208604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
    Mueller GP; Simpkins J; Meites J; Moore KE
    Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin secretion in response to haloperidol challenge in delusional (psychotic) and non-delusional depression.
    Lykouras L; Markianos M; Hatzimanolis J; Oulis P; Christodoulou G
    Eur Psychiatry; 2000 Dec; 15(8):480-2. PubMed ID: 11175925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of lithium treatment on the activity of central dopaminergic neurons].
    Koyama T
    Hokkaido Igaku Zasshi; 1987 May; 62(3):402-16. PubMed ID: 3111963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research.
    Rotrosen J; Angrist B; Gershon S; Paquin J; Branchey L; Oleshansky M; Halpern F; Sachar EJ
    Br J Psychiatry; 1979 Nov; 135():444-56. PubMed ID: 540209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction.
    Borzio M; Caldara R; Ferrari C; Barbieri C; Borzio F; Romussi M
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):441-7. PubMed ID: 7270004
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroendocrine effects of bromperidol.
    Bianchi A; Drago F; Canonico PL; Guarcello V; Carpiniello B; Scapagnini U
    Acta Psychiatr Belg; 1978; 78(1):69-82. PubMed ID: 417559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
    Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor.
    Xu R; Parlow AF; Wang Y
    Brain Res; 2002 Jun; 939(1-2):95-9. PubMed ID: 12020855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of Yohimbine, an alpha2 adrenergic receptor antagonist, on the growth hormone response to apomorphine in normal subjects.
    Lal S; Thavundayil JX; Krishnan B; Nair NP; Schwartz G; Guyda H
    J Psychiatry Neurosci; 1996 Mar; 21(2):96-100. PubMed ID: 8820174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desensitization of the dopaminergic inhibition of pituitary luteinizing hormone release by prolactin in ovariectomized rats.
    Beck W; Wuttke W
    J Endocrinol; 1977 Jul; 74(1):67-74. PubMed ID: 874418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoprolactinemic action of calcitonin and the tuberoinfundibular dopaminergic system.
    Clementi G; Nicoletti F; Patacchioli F; Prato A; Patti F; Fiore CE; Matera M; Scapagnini U
    J Neurochem; 1983 Mar; 40(3):885-6. PubMed ID: 6827284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium.
    Gallager DW; Pert A; Bunney WE
    Nature; 1978 May; 273(5660):309-12. PubMed ID: 652037
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
    Sakuma H; Takase S; Mizuno Y; Teramura K; Hanew K
    Tohoku J Exp Med; 1988 Nov; 156(3):291-8. PubMed ID: 3252557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.